Clinical Trial Update: Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the potential drug-drug interaction between TAK-788 and midazolam in participants with advanced non-small cell lung cancer; results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• TAK-788
• Versed (Midazolam)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2024-04-12